1. The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets
   Chae Won Kim et al, 2021, BMB Reports CrossRef
2. Immunological Network in Head and Neck Squamous Cell Carcinoma—A Prognostic Tool Beyond HPV Status
   Anna Fialová et al, 2020, Frontiers in Oncology CrossRef
3. Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
   Chenhang Yu et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
4. Human Cytomegalovirus Interleukin 10 Homologs: Facing the Immune System
   Emma Poole et al, 2020, Frontiers in Cellular and Infection Microbiology CrossRef
5. Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift
   Matilde Monti et al, 2024, Frontiers in Immunology CrossRef
6. From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past
   Mahdi Abdoli Shadbad et al, 2021, Frontiers in Immunology CrossRef
7. The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC
   Vladimír Koucký et al, 2021, Cancer Immunology, Immunotherapy CrossRef
8. Spatial Profiles of Intratumoral PD-1+ Helper T Cells Predict Prognosis in Head and Neck Squamous Cell Carcinoma
   Kanako Yoshimura et al, 2021, Frontiers in Immunology CrossRef
9. Cytokine profiling in plasma distinguishes the histological inflammatory subtype of head and neck squamous cell carcinoma and a novel regulatory role of osteopontin
   Ioana Ghita et al, 2022, Frontiers in Oral Health CrossRef
10. Exploring the function of myeloid cells in promoting metastasis in head and neck cancer
    Dakota Dike Dimegwu Okwuone et al, 2024, Exploration of Targeted Anti-tumor Therapy CrossRef